DISCOUNT ZERTIFIKAT - EDWARDS LIFESCIENCES | Market Closed - Börse Stuttgart 03:52:49 2024-06-14 EDT | ||
| 77.84 EUR | +0.82% |
|
| Current month | +1.01% | ||
| 1 month | +3.14% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-06-14 | 77.84 | +0.82% |
| 24-06-13 | 77.21 | -0.22% |
| 24-06-12 | 77.38 | +0.62% |
| 24-06-11 | 76.9 | -1.41% |
| 24-06-10 | 78 | +1.67% |
Delayed Quote Börse Stuttgart
Last update June 14, 2024 at 03:52 am
More quotesStatic data
| Product type | Discount-Zertifikate |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
BNP Paribas
|
| WKN | PC56P6 |
| ISIN | DE000PC56P62 |
| Date issued | 2024-03-04 |
| Maturity | 2024-09-20 (96 Days) |
| Parity | 1 : 1 |
| Emission price | 73.56 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 78.21 € |
|---|---|
| Lowest since issue | 73.46 € |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
87.29
USD
Average target price
96.24
USD
Spread / Average Target
+10.25%
- Stock Market
- Certificates
- Certificat
